Predicting early recurrence in resectable rectal cancer

doi:10.4240/wjgs.v17.i8.101227

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=0

Aug 27, 2025 (publication date) through Aug 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Surg. Aug 27, 2025; 17(8): 101227
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.101227

Predicting early recurrence in resectable rectal cancer

Manuel Carmo Silva, Tiago Correia de Sá, Kayla P Pereira, Joana M Pisco

Manuel Carmo Silva, Kayla P Pereira, Joana M Pisco, Department of Radiotherapy, ULS Santa Maria, Lisbon 1649-028, Portugal

Tiago Correia de Sá, Hepatobiliopancreatic Surgery and Transplantation Service, Unidade Local de Saude Santo Antonio, Porto 4150, Portugal

Co-first authors: Manuel Carmo Silva and Tiago Correia de Sá.

Author contributions: Carmo Silva M, Correia de Sá T, Pereira KP, and Pisco JM contributed to this paper; Carmo Silva M designed the overall concept, outline, and design of the manuscript and performed the literature review; Carmo Silva M, Correia de Sá T, Pereira KP, and Pisco JM contributed to the discussion, as well as the writing and editing of the manuscript; All authors have read and approved the final manuscript.

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Manuel Carmo Silva, MD, Doctor, Department of Radiotherapy, ULS Santa Maria, Av. Prof. Egas Moniz MB, Lisbon 1649-028, Portugal. mj.oliveiracampos@gmail.com

Received: September 8, 2024
Revised: March 16, 2025
Accepted: March 26, 2025
Published online: August 27, 2025
Processing time: 350 Days and 15.3 Hours

Core Tip

Core Tip: The identification of an 8-month cut-off to distinguish early recurrence (ER) from late recurrence in rectal cancer emphasizes the importance of targeted surveillance in this period. Factors such as advanced age, preoperative chemoradiotherapy, and longer hospital stays highlight patient subsets that require intensive follow-up. Enhanced surveillance protocols with advanced imaging and molecular biomarkers could better manage recurrence and define risk groups for ER, improving treatment strategies and thus survival outcomes and patients’ quality of life.